Evidence for the Additional Health Benefits Associated with Phosphodiesterase 5 Inhibitors when Used for Treating Erectile Dysfunction, with a Focus on Prostate Cancer Patients and Other Associated Conditions.

Saved in:
Bibliographic Details
Title: Evidence for the Additional Health Benefits Associated with Phosphodiesterase 5 Inhibitors when Used for Treating Erectile Dysfunction, with a Focus on Prostate Cancer Patients and Other Associated Conditions.
Authors: Naranjo A; Prostate Cancer UK, London, UK. alexandra.naranjo@prostatecanceruk.org., Hackett GI; Aston University Medical School, Birmingham, UK., Smith S; Prostate Cancer UK, London, UK., Stephens H; Bristol Cancer Institute, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Kinnaird W; Cancer Division, University College London Hospitals NHS Foundation Trust, London, UK., Kirby M; Prostate Cancer UK, London, UK.
Source: The world journal of men's health [World J Mens Health] 2026 Jul; Vol. 44 (3), pp. 582-592. Date of Electronic Publication: 2026 Feb 13.
Publication Type: Journal Article; Review
Journal Info: Publisher: Korean Society for Sexual Medicine and Andrology Country of Publication: Korea (South) NLM ID: 101596899 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2287-4208 (Print) Linking ISSN: 22874208 NLM ISO Abbreviation: World J Mens Health Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41714897
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evidence for the Additional Health Benefits Associated with Phosphodiesterase 5 Inhibitors when Used for Treating Erectile Dysfunction, with a Focus on Prostate Cancer Patients and Other Associated Conditions.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Naranjo+A%22">Naranjo A</searchLink>; Prostate Cancer UK, London, UK. alexandra.naranjo@prostatecanceruk.org.<br /><searchLink fieldCode="AU" term="%22Hackett+GI%22">Hackett GI</searchLink>; Aston University Medical School, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Smith+S%22">Smith S</searchLink>; Prostate Cancer UK, London, UK.<br /><searchLink fieldCode="AU" term="%22Stephens+H%22">Stephens H</searchLink>; Bristol Cancer Institute, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Kinnaird+W%22">Kinnaird W</searchLink>; Cancer Division, University College London Hospitals NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Kirby+M%22">Kirby M</searchLink>; Prostate Cancer UK, London, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101596899%22">The world journal of men's health</searchLink> [World J Mens Health] 2026 Jul; Vol. 44 (3), pp. 582-592. <i>Date of Electronic Publication: </i>2026 Feb 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Korean+Society+for+Sexual+Medicine+and+Andrology%22">Korean Society for Sexual Medicine and Andrology </searchLink><i>Country of Publication: </i>Korea (South) <i>NLM ID: </i>101596899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2287-4208 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222874208%22">22874208 </searchLink><i>NLM ISO Abbreviation: </i>World J Mens Health <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41714897
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.5534/wjmh.250313
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 582
    Titles:
      – TitleFull: Evidence for the Additional Health Benefits Associated with Phosphodiesterase 5 Inhibitors when Used for Treating Erectile Dysfunction, with a Focus on Prostate Cancer Patients and Other Associated Conditions.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Naranjo A
      – PersonEntity:
          Name:
            NameFull: Hackett GI
      – PersonEntity:
          Name:
            NameFull: Smith S
      – PersonEntity:
          Name:
            NameFull: Stephens H
      – PersonEntity:
          Name:
            NameFull: Kinnaird W
      – PersonEntity:
          Name:
            NameFull: Kirby M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2287-4208
          Numbering:
            – Type: volume
              Value: 44
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: The world journal of men's health
              Type: main
ResultId 1